CHEK2 and ovarian carcinoma: In another study, Baysal and colleagues [79] identified del1100C and A252G variants of CHEK2, but since the differences in variant frequency were not statistically significant compared to controls, it was concluded that variations in CHEK2 were not associated with ovarian cancer pathogenesis.